This study, called PReSeRVE-HD, is an observational study looking at how well two medical devices, the HeRO® Graft System and the Super HeRO® System, work for people on hemodialysis (a treatment for kidney failure). These devices are used when other options for maintaining long-term dialysis access have not worked. The study aims to better understand the safety and performance of these devices. You could join if you are an adult (18 or older) with end-stage renal disease (kidney failure) on hemodialysis and are being treated with either the HeRO Graft or Super HeRO System. The study will measure a combined outcome (composite endpoint) at 6 months to see how successful the devices are. The current recruitment status is unclear.

Study design

This is an observational study with a planned enrollment of 100 participants.

What's involved

You would be followed over 2 years, with 4 visit timepoints. If you don't have a standard clinic visit, you will be contacted by phone to check your health and dialysis status.

Compensation

Not stated in the trial record.

Follow-up

Participants are followed for 2 years, with the primary endpoint measured at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.